Reduction of debt by conversion
Copenhagen, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Announcement (
Selskabsmeddelelse) no. 1-2021
Following a request from lender (Formue Nord), the company has agreed to issue new shares corresponding to convertible debt of DKK 2 million. This in accordance with the loan agreement.
The transaction will be initiated immediately after this announcement, where 215.205 new shares will be issued, corresponding to 2,42% of the total number of shares after the issue. The share price for the conversion is set as an average of the previous five trading days’ VWAP minus a discount of 10%.
For the company, this debt reduction is a positive step towards further strengthening of the company’s capital structure.
About Hypefactors A/S
Hypefactors is an integrated AI powered Earned Media tech platform to support better media intelligence and reputation management.
Hypefactors combine data, analytics, technology and tools to provide a unified and easy-to-use experience. With all the tools to automate and ease the work, and all the facts to document the results. In addition to media monitoring across the different media channels, the platform provides access to a number of facts, incl. automated documentation of the monetary value and quality assessment of each third party media mention. The platform also contains other time-saving tools such as automatically generated media reports and a mobile app giving access to real-time media mentions. The company is listed at Nasdaq Growth Market in Copenhagen, Denmark.
For more information, please contact:
Casper Janns, CEO: Tlf.: +45 20167481, e-mail: email@example.com
Pierre André Montjovet, Chairman of the Board: Tlf: +41 (0)78 922 33 0
1306 Copenhagen K
Kapital Partner ApS
Jesper Ilsøe, tlf. +4526802728
1608 Copenhagen V
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S26.1.2021 12:47:12 CET | Press release
Genmab Announces 2020 Net Sales of DARZALEX® (daratumumab)
Tryg A/S26.1.2021 12:03:20 CET | Press release
Corporate Responsibility report 2020
Evli Bank Plc26.1.2021 12:01:49 CET | Press release
Evli Bank Plc - Managers' Transactions
Uponor Corporation26.1.2021 12:01:39 CET | Press release
Proposals by Uponor Nomination Board to the Annual General Meeting 2021
Sveriges Riksbank26.1.2021 11:31:37 CET | Press release
RESULT OF RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS
Interop Technologies26.1.2021 11:05:35 CET | Press release
RCS users to grow 294% by 2024, driving new revenue for mobile operators
Active Biotech26.1.2021 11:01:35 CET | Press release
Active Biotech’s rights issue heavily oversubscribed
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom